PF4V1 and melanoma: Another comparison includes the COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70), which when injected intra-tumourally was also described as a successful therapy in B16F10 melanoma growth in vivo [48].